Tradestie Institutional Equity Comparison Engine

DMAC vs ZVRA โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

ZVRA Overall Edge

ZVRA Captures Institutional Edge (2โ€“2 Pillars ยท 9โ€“1 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Zevra Therapeutics, Inc. Common Stock (ZVRA) driven by superior Valuation, Growth & Margin while DMAC counters with relative strength in Momentum & Technical, Options & Structure. Fundamentally, DMAC trades at N/M Forward P/E with 0.0% operating margin (+0.0% YoY revenue) versus ZVRA at 9.3x Forward P/E and 31.5% operating margin (+44.9% YoY). In options structure, DMAC sits in SURGE (14th %ile IV; Dealer Gamma Walls on Pro) against ZVRA sits in BREAKDOWN (14th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner ZVRA
DMAC N/M vs ZVRA 9.3x Fwd P/E
Growth & Margin Winner ZVRA
Op Margin 0.0% vs 31.5% ยท YoY +0.0% vs +44.9%
Momentum & Technical Winner DMAC
1Y +55.3% vs +0.9% ยท 52W Pos 55% vs 18%
Options & Structure Winner DMAC
SURGE (14th %ile IV) vs BREAKDOWN (14th %ile IV)
DMAC NASDAQ
DiaMedica Therapeutics Inc. Common Stock
Pharmaceutical Preparations
$8.41
-4.27% 1D
Market Cap $503.1M
1M Return +11.16%
1Y Return +55.26%
Forward P/E N/M
Unified AI Score
46.3 / 100 HOLD
Tech 30.0 Fund 51.0 Flow 65.0 Mom 60.0
ZVRA NASDAQ
Zevra Therapeutics, Inc. Common Stock
Pharmaceutical Preparations
$9.31
+2.53% 1D
Market Cap $664.1M
1M Return -6.34%
1Y Return +0.87%
Forward P/E 9.3x
Unified AI Score
49.3 / 100 HOLD
Tech 36.0 Fund 54.0 Flow 67.0 Mom 60.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: DMAC +55.26% ZVRA +0.87% Spread: +54.39 pp (DMAC Lead)

Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant Revenue ($B) & Operating Margin (%)
Period DMAC Revenue ZVRA Revenue DMAC Op. Margin ZVRA Op. Margin Margin Edge
FY2018 $0M N/A -1352.2% N/A DMAC
FY2019 N/A $10M N/A -158.4% ZVRA
FY2020 N/A $10M N/A -42.2% ZVRA
FY2021 N/A $30M N/A 27.0% ZVRA
FY2022 N/A $10M N/A -418.9% ZVRA
FY2023 N/A $30M N/A -180.6% ZVRA
FY2024 N/A $20M N/A -368.5% ZVRA
FY2025 N/A $110M N/A -59.1% ZVRA

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: DMAC (1) vs ZVRA (9)
Institutional Metric DMAC ZVRA Criterion Row Winner
Market Capitalization Scale $503.1M $664.1M Larger Scale ZVRA
Trailing P/E Ratio Valuation N/M 9.7x Lower Multiple ZVRA
Forward P/E Ratio Valuation N/M 9.3x Lower Multiple ZVRA
Revenue Growth (YoY) Growth +0.0% +44.9% Higher Growth ZVRA
Operating Margin (TTM) Profitability 0.0% 31.5% Higher Margin ZVRA
Net Profit Margin Profitability 0.0% 52.8% Higher Margin ZVRA
Return on Equity (ROE) Capital Efficiency -114.6% 41.9% Higher ROE ZVRA
52-Week Range Position Momentum 55% ($5โ€“$11) 18% ($8โ€“$15) Stronger Trend DMAC
Beta / 30D Volatility Risk Regime 1.74ฮฒ ยท 98% Vol 1.18ฮฒ ยท 95% Vol Lower Realized Risk ZVRA
Unified Institutional Score Composite Signal 46.3 / 100 (HOLD) 49.3 / 100 (HOLD) Higher Composite ZVRA

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full DMAC vs ZVRA Buy Guide
DMAC SURGE
8d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 14th %ile
IV Regime Compressed (<25th %ile)
Live DMAC Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
ZVRA BREAKDOWN
111d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 14th %ile
IV Regime Compressed (<25th %ile)
Live ZVRA Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither DMAC nor ZVRA registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.